Clinical Trial for Vascular Dementia
Clinical Trial for Vascular Dementia.
A Multicentre, Randomised, Double-Blind, Placebo Controlled Trial to Evaluate the Effectiveness and Safety of Sailuotong (SLT), a Standardised Herbal Medicine Formula in Patients with Vascular Dementia and Alzheimer’s Disease with Cerebrovascular Disease.
Vascular dementia (VaD) is a major cause of mental and physical disability in the aging populations of the western countries. It is the second most common cause of dementia after Alzheimer’s disease and accounts for 15-20% of all cases of dementing disorders. The purpose of this research is to investigate the effectiveness and safety of a standardized Chinese herbal medicine formula, Sailuotong (SLT), in the treatment of patients with vascular dementia or Alzheimer’s disease with cerebrovascular disease. This study is being conducted because there are no current approved pharmaceutical treatments available.Travel expenses will be paid up to $30 per visit. Your participation will involve taking the treatment for 52 weeks, and attending 8 scheduled clinic visits and 1 scheduled telephone call over 65 weeks
Unable to participate in this trial? Register for similar trials.